- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Pulse Online rolling banner for Nicorette included the generic name but the first banner lacked a clear, prominent single-click link to prescribing…
Anonymous complaint about Sanofi reps’ call-rate expectations. Panel found no proof of over-calling, but a manager email pushing higher contact rates without…
Biogen UK was found in breach for late disclosure of three Phase I/II Tecfidera trials. Results should have been public by 27…
Celgene’s Otezla “meetings in a box” slide decks were certified as if for rep use only, but were also used by HCPs.…
ABBH nurse audit programme materials linked offering an osteoporosis audit service to agreement to prescribe Actonel. Breaches of Clauses 18.1 and 2…
Roche’s BMJ MabThera ad showing a high-jump athlete and “Recommended by NICE” was challenged as misleading and raising false hope. The PMCPA…
A GP complained an MSD meeting invitation looked unprofessional and unclear. The Panel found the company identity and meeting arrangements were clear…
Ferriprox banner ad linked UK clinicians to a page reusing “Life is Getting Longer…”, previously ruled a hanging comparison. Panel found breach…
A PCT complained an AstraZeneca rep missed a rebooked appointment and didn’t explain. Panel criticised use of a personal PDA with no…
Schering placed a LARC information feature in an M&S magazine. Complaint alleged missing progestogen safety warnings. Panel found the piece didn’t discuss…
Lilly sponsored a freelance journalist to attend ESSM where a Cialis symposium (incl. unlicensed once-daily regimen) was compulsory. Two lay-press articles followed.…
A paid-for journal ad promoting awareness of GSK’s TORCH COPD study was deemed an indirect product advertisement for Serevent/Flixotide/Seretide and breached the…
PMCPA case AUTH/3002/12/17 (Director v Octapharma) concerning clinical trial disclosure for Nuwiq. Outcome: No breach; matter found to be outwith the scope…
PMCPA case AUTH/2788/8/15: complaint about paying for a Lyrica switch. Outcome: No breach; matter considered outwith the scope of the Code.
PMCPA recorded the complaint as outwith the scope of the ABPI Code (2012). No breach was found and no case report was…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.